Hans Biomed (XKRX:042520) EV-to-EBITDA : -18.68 (As of May. 27, 2024)

Hans Biomed EV-to-EBITDA Chart

Hans Biomed Annual Data
	Trend	Sep14	Sep15	Sep16	Sep17	Sep18	Sep19	Sep20	Sep21	Sep22	Sep23
EV-to-EBITDA		Get a 7-Day Free Trial					16.77	-21.13	-14.63	9.32	-18.93

Hans Biomed Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
EV-to-EBITDA	Get a 7-Day Free Trial															11.04	939.81	-163.82	-18.93	-20.14

Competitive Comparison of Hans Biomed's EV-to-EBITDA

For the Medical Devices subindustry, Hans Biomed's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Hans Biomed's EV-to-EBITDA Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Hans Biomed's EV-to-EBITDA distribution charts can be found below:

* The bar in red indicates where Hans Biomed's EV-to-EBITDA falls into.

Hans Biomed EV-to-EBITDA Calculation

Hans Biomed's EV-to-EBITDA for today is calculated as:

Hans Biomed's current Enterprise Value is ₩197,435 Mil.
Hans Biomed's EBITDA for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was ₩-10,571 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Hans Biomed  (XKRX:042520) EV-to-EBITDA Explanation

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

Hans Biomed's PE Ratio for today is calculated as:

Hans Biomed's share price for today is ₩13550.00.
Hans Biomed's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was ₩-1837.000.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio.

Please read Which price ratio outperforms the enterprise multiple?

Hans Biomed EV-to-EBITDA Related Terms

Thank you for viewing the detailed overview of Hans Biomed's EV-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.

Hans Biomed (XKRX:042520) Business Description